Brief: Addex Therapeutics Extends Collaboration With Prominent Swiss Biotech
Feb 24 (Reuters) - ADDEX THERAPEUTICS LTD ADXN.S :
* EXTEND COLLABORATION WITH PROMINENT SWISS BIOTECH
* NEW MULTI-YEAR DRUG DISCOVERY AGREEMENT WILL FOCUS ON CNS
DRUG
DISCOVERY
* ADDEX THERAPEUTICS OWNING ALL RESULTING INTELLECTUAL
PROPERTY
RIGHTS
Source text for Eikon: ID:nBw8X5n5va
Further company coverage: ADXN.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))
Recent news on Addex Therapeutics
See all newsBrief: Addex Spin-Out Neurosterix Completes Phase 1 Clinical Studies Of NTX-253 For Schizophrenia
NASDAQ RESUMED AT 11:29 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:24 AM
Switzerland's Addex Therapeutics Q2 net loss narrows on decline in R&D expenses
Brief: Addex Therapeutics Q2 Operating Income CHF -645 Thousand